HEARTCARE-B: EXTENSION OF THE VALIDITY PERIOD OF THE RESOLUTIONS CONCERNING THE A SHARE ISSUE AND THE AUTHORIZATION CONCERNING THE A SHARE ISSUE; PROPOSED CHANGE OF REGISTERED ADDRESS AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
HEARTCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2024
HEARTCARE-B: INTERIM REPORT 2024
HEARTCARE-B: CLOSURE OF H SHARE REGISTER OF MEMBERSFOR EXTRAORDINARY GENERAL MEETING ANDCLASS MEETING OF H SHAREHOLDERS
HEARTCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2024
HEARTCARE-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
HEARTCARE-B: TERMS OF REFERENCE FORTHE STRATEGY COMMITTEE OF THE BOARD OF DIRECTORS
HEARTCARE-B: ESTABLISHMENT OF STRATEGY COMMITTEE OF THE BOARDOF DIRECTORS
HEARTCARE-B: ANNOUNCEMENT OF INTERIM RESULTS FORTHE SIX MONTHS ENDED JUNE 30, 2024
HEARTCARE-B: DATE OF BOARD MEETING
HEARTCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
HEARTCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
HEARTCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
HEARTCARE-B: POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING HELD ON MAY 20, 2024
HEARTCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
HEARTCARE-B: PROXY FORM FOR USE ATTHE 2023 ANNUAL GENERAL MEETING
HEARTCARE-B: (1) WORK REPORT OF THE BOARD OF DIRECTORS FOR 2023(2) WORK REPORT OF THE SUPERVISORY COMMITTEE FOR 2023(3) PROFIT DISTRIBUTION PLAN FOR 2023(4) AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR 2023(5) 2023 ANNUAL REPORT(6) PROPOSED AMENDMENTS TO THE 2021
HEARTCARE-B: NOTICE OF 2023 ANNUAL GENERAL MEETING
HEARTCARE-B: ANNUAL REPORT 2023
HEARTCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
No Data
No Data